TET1 and pulmonary fibrosis: 65 (73.0%) enriched pathways following HDM treatment were also enriched following TET1 knockdown, including TGF-β Signaling and Pulmonary Fibrosis Idiopathic Signaling Pathway (Supplementary Table 2).